BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 29603764)

  • 1. A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.
    Li J; Huang XF; Cai QQ; Wang C; Cai H; Zhao H; Zhang L; Cao XX; Gale RP; Zhou DB
    Am J Hematol; 2018 Jun; 93(6):803-809. PubMed ID: 29603764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.
    Gao Y; Zhang S; Yang L; Li J; Liu Y; Wang T
    Front Immunol; 2021; 12():681360. PubMed ID: 34025681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial.
    Suichi T; Misawa S; Nagashima K; Sato Y; Iwai Y; Katayama K; Sekiguchi Y; Shibuya K; Amino H; Suzuki YI; Tsuneyama A; Nakamura K; Kuwabara S
    Intern Med; 2020 May; 59(9):1149-1153. PubMed ID: 32009091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome.
    Gao XM; Yu YY; Zhao H; Cai H; Zhang L; Cao XX; Zhou DB; Li J
    Ann Hematol; 2021 Nov; 100(11):2755-2761. PubMed ID: 34331562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
    He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
    Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
    Suichi T; Misawa S; Sekiguchi Y; Shibuya K; Nakamura K; Kano H; Aotsuka Y; Otani R; Morooka M; Tsukamoto S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Kuwabara S
    Intern Med; 2022; 61(17):2567-2572. PubMed ID: 36047093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome.
    Cai QQ; Wang C; Cao XX; Cai H; Zhou DB; Li J
    Eur J Haematol; 2015 Oct; 95(4):325-30. PubMed ID: 25401269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.
    Nozza A; Terenghi F; Gallia F; Adami F; Briani C; Merlini G; Giordano L; Santoro A; Nobile-Orazio E
    Br J Haematol; 2017 Dec; 179(5):748-755. PubMed ID: 29048107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome.
    Li J; Zhang W; Jiao L; Duan MH; Guan HZ; Zhu WG; Tian Z; Zhou DB
    Blood; 2011 Jun; 117(24):6445-9. PubMed ID: 21393478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
    Misawa S; Sato Y; Katayama K; Nagashima K; Aoyagi R; Sekiguchi Y; Sobue G; Koike H; Yabe I; Sasaki H; Watanabe O; Takashima H; Nishizawa M; Kawachi I; Kusunoki S; Mitsui Y; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
    Lancet Neurol; 2016 Oct; 15(11):1129-37. PubMed ID: 27496680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients.
    Lestang E; Caristan A; Néel A; Graveleau J; Duhamel E; Masseau A; Connault J; Maisonneuve H; Le Gouill S; Blin N; Touzeau C; Moreau P; Hamidou M
    Leuk Lymphoma; 2015 Jun; 56(6):1895-6. PubMed ID: 25347429
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
    Khouri J; Nakashima M; Wong S
    JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients.
    Royer B; Merlusca L; Abraham J; Musset L; Haroche J; Choquet S; Leleu X; Sebban C; Decaux O; Galicier L; Roussel M; Recher C; Banos A; Guichard I; Brisseau JM; Godmer P; Hermine O; Deplanque G; Facon T; Asli B; Leblond V; Fermand JP; Marolleau JP; Jaccard A
    Am J Hematol; 2013 Mar; 88(3):207-12. PubMed ID: 23335406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of optic disc edema area in estimating the severity of papilledema in patients with POEMS syndrome.
    Liu LS; Zhang X; Zhao H; Gao XM; Zhou DB; Dai RP; Li J
    Orphanet J Rare Dis; 2020 May; 15(1):116. PubMed ID: 32429967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy.
    Briani C; Manara R; Lessi F; Citton V; Zambello R; Adami F
    Am J Hematol; 2012 May; 87(5):539-41. PubMed ID: 22389216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lenalidomide and Dexamethasone for a Patient of POEMS Syndrome Presenting with Massive Ascites.
    Ueda S; Yonemoto S; Oka K; Fujii N; Nakata K; Matsunaga H; Kataoka S; Iwama Y; Narahara H; Yasunaga Y; Inui Y; Kawata S
    Case Rep Hematol; 2014; 2014():818946. PubMed ID: 24782932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?
    Zhao H; Huang XF; Gao XM; Cai H; Zhang L; Feng J; Cao XX; Zhou DB; Li J
    Leukemia; 2019 Apr; 33(4):1023-1029. PubMed ID: 30700844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial.
    Katayama K; Misawa S; Sato Y; Sobue G; Yabe I; Watanabe O; Nishizawa M; Kusunoki S; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
    BMJ Open; 2015 Jan; 5(1):e007330. PubMed ID: 25573527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone.
    Yang H; Huang X; Cai Q; Wang C; Cao X; Zhou D; Li J
    Orphanet J Rare Dis; 2016 Jun; 11(1):80. PubMed ID: 27317315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of POEMS syndrome with lenalidomide and dexamethasone].
    Goto A; Iyama S; Sugama Y; Yoshida M; Ibata S; Tatekoshi A; Fujita C; Kikuchi S; Ikeda H; Murase K; Takada K; Kato J; Kobune M
    Rinsho Ketsueki; 2019; 60(4):308-313. PubMed ID: 31068561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.